ClinicalTrials.gov
ClinicalTrials.gov Menu

Olive Oil With Omega 3 to Treat Stasis Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00421161
Recruitment Status : Unknown
Verified January 2007 by Assaf-Harofeh Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : January 11, 2007
Last Update Posted : January 11, 2007
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center

January 10, 2007
January 11, 2007
January 11, 2007
January 2007
Not Provided
improvement in subjective and objective skin changes of patient: pain, edema, redness, size of involement,
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Olive Oil With Omega 3 to Treat Stasis Dermatitis
Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis
Olive oil and Omega 3 have many anti inflammatory effects that may be beneficial in the inflammation and edema of chronic stasis dermatitis. The olive oil contains many mono unsaturated fatty acids and anti oxidants that may add to the well being of a diseased skin by improving cell membrane homeostasis.
Patients with chronic stasis dermatitis due to venous insufficiency will be treated with the study cream and as control we will use "Venoroutone" . Patients will be followed weekly at the clinic of the vascular surgery at Assaf Harofeh MC.
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Treatment
Dermatitis
Drug: olive oil and omega 3 in a combined cream
Not Provided
Sapino S, Carlotti ME, Peira E, Gallarate M. Hemp-seed and olive oils: their stability against oxidation and use in O/W emulsions. J Cosmet Sci. 2005 Jul-Aug;56(4):227-51.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
30
Same as current
March 2007
Not Provided

Inclusion Criteria:

  • Patints with stasis dermatitis for 6 months at least

Exclusion Criteria:

  • skin ulceration or infection
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00421161
Refael Segal
Not Provided
Not Provided
Not Provided
Not Provided
Assaf-Harofeh Medical Center
Not Provided
Principal Investigator: Arie Bass, MD Assaf Harofe MC
Assaf-Harofeh Medical Center
January 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP